Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-25 @ 7:34 PM
NCT ID:
NCT02066532
Group ID:
EG000
Title:
Phase 1 and 2: Ruxolitinib/Trastuzumab (25 mg)
Description:
Ruxolitinib: 25 mg bid on days 1 through 21 of each 21 day cycle. Number of Cycles: until progression or unacceptable toxicity develops.
Trastuzumab: 6 mg/kg every 3 weeks (cycle = 21 days). If no trastuzumab \> 28 days, patients will be initially re-loaded at 8 mg/kg, then 6 mg/kg.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
26
Other Number Affected:
26
Other Number At Risk:
26
Study:
NCT02066532
Results Section:
NCT02066532
Adverse Events Module:
NCT02066532